We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+25.11%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$272M
AUM Growth
+$16.2M
Cap. Flow
-$33.7M
Cap. Flow %
-12.39%
Top 10 Hldgs %
50.22%
Holding
97
New
4
Increased
11
Reduced
69
Closed
10

Top Buys

Rank Stock Value
1
OCLR
Oclaro Inc.
OCLR
+$3.07M
2
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$2.94M
3
OMCL icon
Omnicell
OMCL
+$2.65M
4
SCON
Superconductor Technologies Inc.
SCON
+$2.41M
5
TLAB
TELLABS INC
TLAB
+$1.68M

Top Sells

Rank Stock Value
1
AKRX
Akorn Inc
AKRX
+$6.1M
2
ARRY
Array Biopharma Inc
ARRY
+$4.63M
3
TEAR
TearLab Corporation
TEAR
+$3.87M
4
STKL
SunOpta
STKL
+$2.79M
5
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
+$2.7M

Sector Composition

Rank Sector Weight
1 Healthcare 41.42%
2 Technology 31.73%
3 Miscellaneous 17.3%
4 Consumer Staples 4.15%
5 Financials 1.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANGO icon
26
AngioDynamics
ANGO
$652M
$2.35M 0.86%
177,715
-11,401
-6% -$134K
CTCT
27
DELISTED
CONSTANT CONTACT, INC COM
CTCT
$2.25M 0.83%
95,218
-18,803
-16% -$358K
NEO icon
28
NeoGenomics
NEO
$2.39B
$2.22M 0.82%
739,495
+144,920
+24% +$408K
ACCL
29
DELISTED
Accelrys Inc
ACCL
$2.22M 0.81%
225,326
-20,319
-8% -$185K
LCI
30
DELISTED
Lannett Company, Inc.
LCI
$1.94M 0.71%
22,225
-4,690
-17% -$274K
LGND icon
31
Ligand Pharmaceuticals
LGND
$5.67B
$1.87M 0.69%
69,152
-10,003
-13% -$281K
IL
32
DELISTED
IntraLinks Holdings Inc.
IL
$1.82M 0.67%
207,239
-24,960
-11% -$218K
NVDQ
33
DELISTED
Novadaq Technologies Inc.
NVDQ
$1.78M 0.65%
107,247
-28,435
-21% -$404K
TQNT
34
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
$1.72M 0.63%
211,961
+12,368
+6% +$94.5K
TLAB
35
DELISTED
TELLABS INC
TLAB
$1.69M 0.62%
+742,690
New +$1.68M
HSTM icon
36
HealthStream
HSTM
$843M
$1.64M 0.6%
43,289
-6,089
-12% -$199K
OPLK
37
DELISTED
OPLINK COMMUNICATIONS INC
OPLK
$1.6M 0.59%
85,050
-106,834
-56% -$2.1M
NPSP
38
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$1.56M 0.57%
48,905
-7,140
-13% -$164K
REGN icon
39
Regeneron Pharmaceuticals
REGN
$83.2B
$1.55M 0.57%
4,969
-994
-17% -$261K
THOR
40
DELISTED
THORATEC CORPORATION
THOR
$1.44M 0.53%
38,519
-3,976
-9% -$139K
EXTR icon
41
Extreme Networks
EXTR
$3.03B
$1.39M 0.51%
+266,915
New +$1.09M
ROCM
42
DELISTED
ROCHESTER MEDICAL CORP
ROCM
$1.29M 0.47%
64,558
-18,710
-22% -$305K
CPHD
43
DELISTED
Cepheid Inc
CPHD
$1.25M 0.46%
31,906
-7,462
-19% -$270K
ALKS icon
44
Alkermes
ALKS
$8.2B
$1.23M 0.45%
36,604
-5,430
-13% -$177K
RKUS
45
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$1.18M 0.44%
70,355
-8,242
-10% -$120K
EOG icon
46
EOG Resources
EOG
$75.8B
$1.04M 0.38%
12,350
+1,290
+12% +$100K
BLK icon
47
Blackrock
BLK
$181B
$1M 0.37%
3,710
-110
-3% -$29.9K
GNMK
48
DELISTED
GenMark Diagnostics, Inc
GNMK
$992K 0.36%
81,708
-14,676
-15% -$157K
MMM icon
49
3M
MMM
$92.2B
$974K 0.36%
9,755
-95
-1% -$9.24K
WFC icon
50
Wells Fargo
WFC
$257B
$971K 0.36%
23,503
-245
-1% -$10.5K
1
2
3 4

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Kopp Investment Advisors held 97 positions worth $272M, up 6.3% from $256M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Kopp Investment Advisors withdrew a net $33.7M in Q3 2013, closing 10 positions and reducing 69 holdings. Its most notable exit was SANGAMO THERAPEUTICS INC, an estimated $2.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 48% a quarter earlier, followed by Technology and Miscellaneous.

Against the trend, Kopp Investment Advisors opened a new position in TELLABS INC worth $1.69M.

  • Kopp Investment Advisors's largest Q3 2013 buy was TELLABS INC: 742,690 shares worth $1.69M.
  • Kopp Investment Advisors added most to Oclaro Inc. in Q3 2013, an estimated $3.07M increase.
  • Kopp Investment Advisors's biggest Q3 2013 reduction was Akorn Inc, cutting an estimated $6.1M.
  • Kopp Investment Advisors fully exited SANGAMO THERAPEUTICS INC in Q3 2013, selling an estimated $2.5M.
  • Kopp Investment Advisors's ten largest holdings make up 50% of its $272M portfolio in Q3 2013.
  • Kopp Investment Advisors opened 4 new positions and closed 10 in Q3 2013.
  • Kopp Investment Advisors's portfolio value rose 6.3% quarter-over-quarter to $272M.

Based on Kopp Investment Advisors's 13F filing for Q3 2013, filed 1 Nov 2013.